Trials / Completed
CompletedNCT04433429
Nutraceuticals and Vascular Remodelling
Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated With Nutraceuticals Derived From Red Yeast Rice.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Marcello Rattazzi · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Aim of the study is to assess the effect of a long-term nutraceutical multitarget approach on lipid profile, inflammatory mediators and vascular remodeling in primary cardiovascular prevention in a setting of controlled dietary habits. The nutraceutical combination used in this study consists of a single pill containing 333 mg of RYR, equivalent to 10 mg of Monacolin K, and 30 mg of Coenzyme Q10 (CoQ10).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Liposcudil Plus |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2020-06-16
- Last updated
- 2020-06-16
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04433429. Inclusion in this directory is not an endorsement.